Sauceda-García JM

Language: Spanish
References: 9
Page: 369-371
PDF size: 95.92 Kb.

Text Extraction

No abstract

REFERENCES

1. Brent DA, Birmaher B. British warnings on SSRIs questioned. J Am Acad Child Adolesc Psychiatry 2004;43:379-380.

2. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behavior. JAMA 2004:292;338-343.

3. Food and Drug Administration. Antidepressant use in children, adolescents, and adults. Disponible en: www. fda.gov/cder/drug/antidepressants/default.htm

4. American Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults. J Am Acad Child Adolesc Psychiatry 2002;41(2 Suppl):26S-49S.

5. Sauceda-García JM. Los trastornos por déficit de atención. Ideas falsas y conocimientos actuales. Bol Med Hosp Infant Mex 1997;54:257-260.

6. Barkely RA, Fischer M, Smallish L, Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatric 2003:111;97-109.

7. Volkow ND, Ding Y, Fowler JS. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Physchiatry 1995;52:456-463.

8. Bostic JQ, Rubin DH, Prince J, Schlozman S. Treatment of depression in children and adolescents. J Psychiatr Practice 2005;11(3):141-154.

9. Greenhill LL, Vitello B, Fisher P, Levine J, Davies M, Abikoff H, et al. Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psycho-pharmacology. J Am Acad Child Adolesc Psychiatry 2004;43:1478-1487.